Control of Assistive Devices Via Brain-Computer Interface Technology
Condition(s) studied
Investigational drug(s) / intervention(s)
Assistive Robotic Arm: The intervention involves using the N1 Implant, a wireless brain-computer interface (BCI), to enable participants to control the Assistive Robotic Arm through neural signals.
Study summary
The CONVOY Study is a clinical trial designed to explore the feasibility of participants from the PRIME Study (NCT06429735) using the N1 Implant to control various assistive devices. The main goal is to determine whether participants can successfully modulate their brain activity to control devices, such as an Assistive Robotic Arm (ARA). This study will assess the effectiveness, consistency, and safety of neural control using the ARA and other assistive devices.
Eligibility
Primary outcome measure(s)
- Ability of participants to modulate brain activity for controlling an assistive device via the N1 Implant. — 3-months following first use of the assistive device
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Barrow Neurological Institute | Phoenix | Arizona |
More Neuralink Corp trials in the USA
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06710626 on ClinicalTrials.gov ↗ ← All trials in the USA